Hey Coads. Thanks for posting that quote again. I thought about this after the presso. Seems we've wound down working capital expenditure due to the trial winding up anyway. (Speculation)
We'll likely see this through until another trial starts, hopefully with OPM (other people's money)
- Forums
- ASX - By Stock
- AVR
- Tissue Engineering v. Immunotherapy
Tissue Engineering v. Immunotherapy, page-19
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.35 |
Change
0.000(0.00%) |
Mkt cap ! $352.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 225 | $18.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.50 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 225 | 18.360 |
2 | 383 | 18.130 |
1 | 300 | 18.110 |
1 | 1000 | 18.000 |
1 | 55 | 17.910 |
Price($) | Vol. | No. |
---|---|---|
18.500 | 1000 | 1 |
19.000 | 437 | 1 |
19.700 | 100 | 1 |
19.870 | 202 | 1 |
20.000 | 3400 | 5 |
Last trade - 09.59am 03/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online